Women diagnosed with these common growths had a more than 80 percent higher risk of later developing heart disease than their ...
As three immigrants claim Nobel Prizes in science for the United States this year, experts warn that immigration crackdowns ...
Renowned global leaders will guide scientific strategy in Parkinson’s disease and beyond as company enters clinical ...
A bizarre Christmas dinner invitation, some mysterious carol singers and even a spot of charades. Can you solve all 12 of our ...
It didn’t relent until hundreds of miles of the Central Valley turned into an inland sea, leaving the city of Sacramento ...
Scientific American’s staffers may spend their days embedded in real-world science discoveries, but their nights are often ...
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 998%* — a market-crushing outperformance compared to 194% for the S&P 500. They just ...
Fintel on MSN
Goldman Sachs initiates coverage of Thermo Fisher Scientific (TMO) with buy recommendation
Fintel reports that on December 9, 2025, Goldman Sachs initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a Buy recommendation. Analyst Price Forecast Suggests 11.10% Upside As of December ...
China and Brazil have begun building a joint laboratory for space technologies, Chinese state-owned defence electronics firm ...
Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage ...
FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...
A session at the AHA Scientific Sessions 2025 focused on clinical trials related to cutting edge valve and coronary care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results